Dr. Stephen K. Rhind has over 25 years business development and funding related experience in the pharmaceutical and biomedical industry. Previously he was Senior Vice-President Corporate Development at S-Bio in Singapore (2005-2011), joining them from Pharmagene Plc where he was Vice-President for Business Development for seven years. Prior to this he was Director of Buisness Development at Cantab Pharmaceuticals Plc. Over the years, he has negotiated numerous multimillion dollar deals with a range of Biotechnology and Pharmaceutical companies including GSK, Onyx Pharmaceuticals, Inc., Enzon Pharmaceuticals, Inc., and Tragara Pharmaceuticals, Inc.